Evaluating the TearCare System for treating dry eye disease
Study of the TearCare System in Dry Eye Disease
This study tests if a new treatment called the TearCare system can help adults with dry eye disease feel better and improve their eye health.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 22 Years and up |
| Sex | All |
| Sponsor | Sight Sciences, Inc. Industry-sponsored |
| Locations | 2 sites (Newport Beach, California and 1 other locations) |
| Trial ID | NCT03588624 on ClinicalTrials.gov |
What this trial studies
This study evaluates the safety and effectiveness of a single procedure using the TearCare system for adult patients diagnosed with dry eye disease. Participants will undergo the treatment and be monitored for a month to assess improvements in their symptoms and overall eye health. The study aims to provide insights into the short-term benefits of this innovative approach to managing dry eye conditions.
Who should consider this trial
Good fit: Ideal candidates are adults diagnosed with dry eye disease who exhibit signs and symptoms of the condition.
Not a fit: Patients with active ocular infections, recent ocular surgeries, or significant ocular surface abnormalities may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could significantly improve the quality of life for patients suffering from dry eye disease.
How similar studies have performed: While this approach is relatively novel, similar studies have shown promise in treating dry eye disease with innovative technologies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed with dry eye disease * Signs and symptoms of dry eye disease * Best corrected visual acuity 20/100 or better * Willing and able to comply with study procedures * Willing and able to provide consent Exclusion Criteria: * Active ocular infection or inflammation * History of eyelid, conjunctiva or corneal surgery within the past year. * Recent office-based dry eye treatment, punctal occlusion or punctal plug placement * Contact lens wearer * Significant ocular surface or eyelid abnormalities, recent ocular trauma * Certain corneal surface abnormalities * Use of medications for treatment of dry eye or medications that cause dry eye * Systemic disease that results in dry eye
Where this trial is running
Newport Beach, California and 1 other locations
- Eye Research Institute — Newport Beach, California, United States (Recruiting)
- Kentucky Eye Institute — Lexington, Kentucky, United States (Recruiting)
Study contacts
- Study coordinator: Anne Ripley
- Email: anne@sightsciences.com
- Phone: 6616458546
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.